DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 202691
The generic ingredient in METHYLPREDNISOLONE SODIUM SUCCINATE is methylprednisolone sodium succinate. There are forty drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the methylprednisolone sodium succinate profile page.
Summary for 202691
Tradename: | METHYLPREDNISOLONE SODIUM SUCCINATE |
Applicant: | Hikma Farmaceutica |
Ingredient: | methylprednisolone sodium succinate |
Patents: | 0 |
Therapeutic Class: | Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) Inflammatory Bowel Disease Agents |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | Feb 16, 2016 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
Approval Date: | Feb 16, 2016 | TE: | AP | RLD: | No |
Complete Access Available with Subscription